2004
DOI: 10.1128/aac.48.2.589-595.2004
|View full text |Cite
|
Sign up to set email alerts
|

Determination of ddATP Levels in Human Immunodeficiency Virus-Infected Patients Treated with Dideoxyinosine

Abstract: Clinical failures of the highly active antiretroviral therapy could result from inefficient intracellular concentrations of antiviral drugs. The determination of drug contents in target cells of each patient would be useful in clinical investigations and trials. The purpose of this work was to quantify the intracellular concentration of ddATP, the active metabolite of dideoxyinosine (ddI), in peripheral blood mononuclear cells (PBMCs) of human immunodeficiency virus (HIV)-infected patients treated with ddI. We… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2005
2005
2019
2019

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 43 publications
0
3
0
Order By: Relevance
“…5). Immunoassays have been used without any sample separation (Goujon et al, 1998;Le Saint et al, 2004), but most methods require chromatographic separation before detection.…”
Section: Introductionmentioning
confidence: 99%
“…5). Immunoassays have been used without any sample separation (Goujon et al, 1998;Le Saint et al, 2004), but most methods require chromatographic separation before detection.…”
Section: Introductionmentioning
confidence: 99%
“…5). Immunoassays have been used without any sample separation (Goujon et al, 1998; Le Saint et al, 2004), but most methods require chromatographic separation before detection.…”
Section: Introductionmentioning
confidence: 99%
“…RIA was used by raising antibodies against a stable isostere of ddATP. The three phosphorylated metabolites of ddI (ddAMP, ddADP and ddATP) had to be purified by anion exchange chromatography and the amount of each metabolite was determined with or without prior phosphatase treatment [7]. LC-MS has been applied to quantitate 2 0 ,3 0 -dideoxyadenosine (ddA) which was obtained from dephosphorylation of ddATP present in cellular extracts of cells treated with ddI.…”
Section: Introductionmentioning
confidence: 99%